Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brian Cogley Insider Profile
4 Followers
Brian Cogley, Chief Financial Officer at Coeptis Therapeutics Holdings, holds 30.00K shares in Coeptis Therapeutics Holdings (Ticker: COEP). Most recently, Brian Cogley Bought $5,000 shares of Coeptis Therapeutics Holdings on Jan 17, 2024 for an estimated value of 3.35K.
Brian Cogley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Brian Cogley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brian Cogley
Brian Cogley's Trading History
List of latest transactions for each holding click on a transaction to see Brian Cogley's performance on stock
You May Also Like
Brian Cogley insider profile FAQ
What is the percentage of profitable transactions made by Brian Cogley?
The percentage of profitable transactions made by Brian Cogley is ―.
What is the average return per transaction made by Brian Cogley?
The average return per transaction made by Brian Cogley is ―.
What stocks does Brian Cogley hold?
Brian Cogley holds: COEP stocks.
What was Brian Cogley’s latest transaction?
Brian Cogley latest transaction was an Informative Buy of $3.35K.
What was Brian Cogley's most profitable transaction?
Brian Cogley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brian Cogley's role in Coeptis Therapeutics Holdings?
Brian Cogley's role in Coeptis Therapeutics Holdings is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.